Sepsis still kills fast and often quietly, with an estimated 48.9% mortality among sepsis cases worldwide in 2017 and roughly 270,000 U.S. deaths tied to sepsis in 2017. Even where clinicians move quickly, the gap is measurable, since each hour antibiotics are delayed in septic shock can raise mortality by 7.6%. This post pieces together the outcomes, timing, and system-level costs so you can see where progress is working and where care still slips.
Key Takeaways
- 48.9% sepsis mortality is estimated among sepsis cases globally in 2017
- ~270,000 U.S. sepsis-related deaths occurred in 2017
- Sepsis was among the top 10 causes of maternal death in 2019 in the U.S. (listed as sepsis/other)
- In a multicenter evaluation, blood culture collection time before antibiotics improved from 35% to 60% within 1 hour after protocol rollout
- In a sepsis education program, 200 clinicians completed training and pre/post test scores increased by 18 points (program metric)
- In an ICU stewardship study, 35% of clinicians adjusted antibiotic decisions based on procalcitonin thresholds (survey/usage metric)
- Each hour of delay in antibiotic administration increases mortality in septic shock by 7.6% (retrospective cohort estimate)
- Achieving early goal-directed care is associated with a 16% absolute reduction in 28-day mortality in early septic shock trials
- Patients with septic shock who receive timely source control have improved survival; a meta-analysis reported a hazard ratio 0.67 for mortality
- In the U.S. Medicare fee-for-service population, sepsis accounted for 2.2% of all hospitalizations in 2016 (claims-based estimate)
- A cost-of-illness estimate put the economic burden of sepsis in the U.S. at $24.3 billion annually (2011)
- In the U.S., readmissions after sepsis hospitalizations were 18.0% within 30 days in one study
- The procalcitonin testing market is projected to grow at a CAGR of 7.5% from 2024 to 2030 (forecast)
- In 2019, 73% of U.S. hospitals used electronic sepsis alerts (survey-based estimate)
- In 2020, the global point-of-care testing market was $23.0 billion and is projected to grow (context for sepsis diagnostics adoption)
Sepsis remains deadly worldwide, with rapid recognition and early antibiotics and source control significantly improving survival.
Related reading
01 · Category
Epidemiology Burden4 stats
01
48.9% sepsis mortality is estimated among sepsis cases globally in 2017
02
~270,000 U.S. sepsis-related deaths occurred in 2017
03
Sepsis was among the top 10 causes of maternal death in 2019 in the U.S. (listed as sepsis/other)
04
In 2016, sepsis accounted for 9.1% of all deaths among U.S. adults (all ages)
Interpretation
Epidemiology Burden Interpretation
From an epidemiology burden perspective, sepsis remains a major cause of death globally and in the US, with an estimated 48.9% mortality among cases in 2017 and 270,000 sepsis related deaths in the United States in 2017, while it also contributed to 9.1% of all deaths among US adults in 2016 and ranked among the top 10 causes of maternal death in 2019.
02 · Category
User Adoption12 stats
01
In a multicenter evaluation, blood culture collection time before antibiotics improved from 35% to 60% within 1 hour after protocol rollout
02
In a sepsis education program, 200 clinicians completed training and pre/post test scores increased by 18 points (program metric)
03
In an ICU stewardship study, 35% of clinicians adjusted antibiotic decisions based on procalcitonin thresholds (survey/usage metric)
04
In a hospital program, 1,500 staff were trained in sepsis recognition during 12 months (reach metric)
05
In a U.S. EHR alert trial, the proportion of eligible patients receiving sepsis screening rose to 88% from a baseline of 51%
06
In a 2019 survey, 54% of clinicians reported using lactate as a routine sepsis vital sign (survey statistic)
07
In a real-world study, 90-day follow-up completion after sepsis discharge was 63% with structured discharge plans (process metric)
08
In a survey, 69% of emergency department physicians reported using a sepsis order set when available (usage metric)
09
In a 2020 survey, 62% of U.S. hospitals had a sepsis protocol in place (survey statistic)
10
In a study of antimicrobial stewardship, procalcitonin implementation reduced antibiotic duration by 25% (relative reduction)
11
In a survey of patients/families, 41% reported they learned about sepsis from hospital discharge materials (patient engagement metric)
12
In 2021, 120 U.S. hospitals participated in sepsis collaborative quality improvement programs (participation metric)
Interpretation
User Adoption Interpretation
Overall, user adoption appears to be accelerating across sepsis care, with EHR alerts raising screening to 88% from 51% and blood culture collection timing improving from 35% to 60% within an hour of protocol rollout.
03 · Category
Clinical Outcomes14 stats
01
Each hour of delay in antibiotic administration increases mortality in septic shock by 7.6% (retrospective cohort estimate)
02
Achieving early goal-directed care is associated with a 16% absolute reduction in 28-day mortality in early septic shock trials
03
Patients with septic shock who receive timely source control have improved survival; a meta-analysis reported a hazard ratio 0.67 for mortality
04
In sepsis, 30-day mortality is 25.7% among ICU patients in a large registry analysis
05
Hospital mortality among patients with septic shock was 34.7% in a national cohort study (U.S.)
06
In a systematic review, bundles targeting early recognition and treatment reduced mortality with an odds ratio of 0.80
07
A 2021 meta-analysis found early sepsis identification and management protocols reduced sepsis mortality (OR ~0.83)
08
A 2018 randomized trial found that procalcitonin-guided discontinuation of antibiotics reduced antibiotic duration by about 2.0 days
09
Hydrocortisone replacement in septic shock reduced time to shock reversal by about 2 days compared with placebo in trials
10
A 2020 observational study reported lactate normalization within 6 hours was associated with lower mortality (OR around 0.35)
11
In a meta-analysis, albumin versus crystalloids for septic shock showed no mortality difference, with 90-day mortality RR 0.92
12
In sepsis, adherence to sepsis bundles is associated with a mortality reduction of 3.1 percentage points in a quality-improvement evaluation
13
In the U.S., the Sepsis-3 definition was associated with ~10% reclassification of clinical cases in a validation study
14
Surviving Sepsis Campaign recommendations include initiating 1-hour bundle items within 1 hour (guideline time target)
Interpretation
Clinical Outcomes Interpretation
For clinical outcomes in sepsis, the pattern is clear that faster, protocolized treatment makes a measurable difference, with each hour of delayed antibiotics increasing septic shock mortality by 7.6% and bundle based or early management approaches cutting mortality by around 3.1 percentage points or achieving about 16% absolute reductions in 28 day death in early goal directed care trials.
More related reading
04 · Category
Cost Analysis9 stats
01
In the U.S. Medicare fee-for-service population, sepsis accounted for 2.2% of all hospitalizations in 2016 (claims-based estimate)
02
A cost-of-illness estimate put the economic burden of sepsis in the U.S. at $24.3 billion annually (2011)
03
In the U.S., readmissions after sepsis hospitalizations were 18.0% within 30 days in one study
04
In U.S. data, 30-day sepsis-related readmissions were $5.4 billion annually (cost estimate)
05
The global economic burden of sepsis was estimated at $135.6 billion in 2017 (healthcare costs plus productivity losses)
06
Procalcitonin tests cost about $10-$25 per test in typical U.S. settings (market price ranges reported by clinical economics sources)
07
Sepsis survivors incur higher post-acute costs; one study reported 2.7x higher Medicare costs in the year after sepsis
08
Sepsis is responsible for 2.1% of total healthcare spending in the U.S. (system-wide estimate)
09
In the U.S., sepsis accounts for 5-10% of total inpatient costs in some hospital systems (reported range)
Interpretation
Cost Analysis Interpretation
The cost analysis evidence shows sepsis is a major and persistent financial burden in the U.S., accounting for 2.2% of hospitalizations and about 2.1% of all healthcare spending while costing the U.S. roughly $24.3 billion each year and driving costly readmissions estimated at $5.4 billion annually.
05 · Category
Industry Trends5 stats
01
The procalcitonin testing market is projected to grow at a CAGR of 7.5% from 2024 to 2030 (forecast)
02
In 2019, 73% of U.S. hospitals used electronic sepsis alerts (survey-based estimate)
03
In 2020, the global point-of-care testing market was $23.0 billion and is projected to grow (context for sepsis diagnostics adoption)
04
In a 2021 review, sepsis screening with EHR-based tools improved time to antibiotics by 0.7 hours on average (meta-analytic effect)
05
In 2021, compliance with sepsis bundle elements improved by 12 percentage points after adoption of standardized order sets (quality study figure)
Interpretation
Industry Trends Interpretation
From an industry trends standpoint, sepsis care is accelerating alongside diagnostics and digital tools, with the procalcitonin testing market forecast to rise at a 7.5% CAGR from 2024 to 2030 and EHR-based screening shaving an average 0.7 hours off time to antibiotics.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Sophie Moreland. (2026, February 13). Sepsis Statistics. Gitnux. https://gitnux.org/sepsis-statistics
MLA
Sophie Moreland. "Sepsis Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/sepsis-statistics.
Chicago
Sophie Moreland. 2026. "Sepsis Statistics." Gitnux. https://gitnux.org/sepsis-statistics.
Sources & references
44 datasets cited across this report · attribution is report-level
+30 additional datasets cited (not shown individually)